These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33247675)

  • 21. BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
    Janku F; Claes B; Huang HJ; Falchook GS; Devogelaere B; Kockx M; Bempt IV; Reijans M; Naing A; Fu S; Piha-Paul SA; Hong DS; Holley VR; Tsimberidou AM; Stepanek VM; Patel SP; Kopetz ES; Subbiah V; Wheler JJ; Zinner RG; Karp DD; Luthra R; Roy-Chowdhuri S; Sablon E; Meric-Bernstam F; Maertens G; Kurzrock R
    Oncotarget; 2015 Sep; 6(29):26886-94. PubMed ID: 26330075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.
    Yeo MK; Liang ZL; Oh T; Moon Y; An S; Kim MK; Kim KS; Shong M; Kim JM; Jo YS
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):555-60. PubMed ID: 21609347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison Between Real-Time PCR and Pyrosequencing for Detection of BRAF V600E Mutation in Thyroid Fine-Needle Aspirates.
    Kim WY; Kim H; Hwang TS; Oh SY
    Appl Immunohistochem Mol Morphol; 2017; 25(5):358-365. PubMed ID: 26657877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid detection of K-, N-, H-RAS, and BRAF hotspot mutations in thyroid cancer using the multiplex primer extension.
    Chang YS; Lin IL; Yeh KT; Chang JG
    Clin Biochem; 2013 Oct; 46(15):1572-7. PubMed ID: 23792105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis.
    Kristensen LS; Andersen GB; Hager H; Hansen LL
    Hum Mutat; 2012 Jan; 33(1):264-71. PubMed ID: 21901793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.
    Salvianti F; Massi D; De Giorgi V; Gori A; Pazzagli M; Pinzani P
    Cancer Biomark; 2019; 26(3):271-279. PubMed ID: 31524142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
    Kowalik A; Kowalska A; Walczyk A; Chodurska R; Kopczyński J; Chrapek M; Wypiórkiewicz E; Chłopek M; Pięciak L; Gąsior-Perczak D; Pałyga I; Gruszczyński K; Nowak E; Góźdź S
    PLoS One; 2017; 12(6):e0179691. PubMed ID: 28636673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Next-Generation Sequencing, Quantitative PCR, and Sanger Sequencing for Mutation Profiling of EGFR, KRAS, PIK3CA and BRAF in Clinical Lung Tumors.
    Gao J; Wu H; Shi X; Huo Z; Zhang J; Liang Z
    Clin Lab; 2016; 62(4):689-96. PubMed ID: 27215089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.
    Schnittger S; Bacher U; Haferlach T; Wendland N; Ulke M; Dicker F; Grossmann V; Haferlach C; Kern W
    Blood; 2012 Mar; 119(13):3151-4. PubMed ID: 22331186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
    Chat-Uthai N; Vejvisithsakul P; Udommethaporn S; Meesiri P; Danthanawanit C; Wongchai Y; Teerapakpinyo C; Shuangshoti S; Poungvarin N
    PLoS One; 2018; 13(6):e0198795. PubMed ID: 29879227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients.
    Li X; Yang T; Li CS; Song Y; Lou H; Guan D; Jin L
    Theranostics; 2018; 8(6):1678-1689. PubMed ID: 29556349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation.
    Araujo PP; Marcello MA; Tincani AJ; Guilhen AC; Morari EC; Ward LS
    Pathol Res Pract; 2012 Aug; 208(8):489-92. PubMed ID: 22770943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establishment of a novel TB-ARMS qPCR method for kras mutation detection].
    Yu L; Teng F; Jiang M; Guo J
    Sheng Wu Gong Cheng Xue Bao; 2019 May; 35(5):880-891. PubMed ID: 31223006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of peripheral BRAF(V600E) mutation as a possible novel marker for papillary thyroid carcinomas.
    Kwak JY; Jeong JJ; Kang SW; Park S; Choi JR; Park SJ; Kim EK; Chung WY
    Head Neck; 2013 Nov; 35(11):1630-3. PubMed ID: 23161556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A valuable adjunct to FNA diagnosis of papillary thyroid carcinoma: in-house PCR assay for BRAF T1799A (V600E).
    Kucukodaci Z; Akar E; Haholu A; Baloglu H
    Diagn Cytopathol; 2011 Jun; 39(6):424-7. PubMed ID: 20607744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.
    Martinuzzi C; Pastorino L; Andreotti V; Garuti A; Minuto M; Fiocca R; Bianchi-Scarrà G; Ghiorzo P; Grillo F; Mastracci L
    Endocrine; 2016 Sep; 53(3):672-80. PubMed ID: 26296380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma.
    Pereira NB; Pereira KM; Coura BP; Diniz MG; de Castro WH; Gomes CC; Gomez RS
    J Oral Pathol Med; 2016 Nov; 45(10):780-785. PubMed ID: 27084044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.
    Nagakubo Y; Hirotsu Y; Amemiya K; Oyama T; Mochizuki H; Omata M
    BMC Med Genomics; 2019 Nov; 12(1):162. PubMed ID: 31711486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid detection of mutations in the BRAF gene using real-time polymerase chain reaction and melting curve analysis.
    Ikenoue T; Hikiba Y; Kanai F; Ijichi H; Togo G; Ohta M; Watabe H; Yamaji Y; Okamoto M; Aragaki J; Matsumura M; Kawabe T; Omata M
    Cancer Genet Cytogenet; 2004 Feb; 149(1):68-71. PubMed ID: 15104286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.